Carcinogenesis, Vol. 21, No. 6, 1175-1182,
June 2000
© 2000 Oxford University Press
Molecular Epidemiology and Cancer Prevention |
Role of glutathione in the accumulation of anticarcinogenic isothiocyanates and their glutathione conjugates by murine hepatoma cells
Department of Pharmacology and Molecular Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
Isothiocyanates (ITCs) are abundant in the human diet. Many potently inhibit tumorigenesis induced by a wide variety of chemical carcinogens in rodents. Recently, we observed that several ITCs accumulated to very high concentrations in cultured cells and that their accumulated levels were closely related to their potencies in inducing phase II enzymes [NAD(P)H:quinone reductase and glutathione transferases] that detoxify carcinogens. To elucidate the molecular mechanism responsible for this accumulation, the intracellular chemical identities of two ITCs, sulforaphane [SF, 1-isothiocyanato-(4R,S)-(methylsulfinyl)butane] and benzyl-ITC, were investigated in murine hepatoma cells. Both ITCs accumulated very rapidly to high intracellular concentrations, but, remarkably, most of the intracellular forms of the ITCs were dithiocarbamates resulting from conjugation with reduced glutathione (GSH). For example, the intracellular concentration reached 6.4 mM when cells were exposed to 100 µM SF for 30 min at 37°C and 95% of the accumulated product was the GSH conjugate. Cellular accumulation of each ITC was accompanied by a profound reduction in cellular GSH levels. These findings, together with our previous observation that accumulation of ITCs depended on cellular GSH levels, strongly suggest that intracellular conjugation of ITCs with GSH is mainly responsible for ITC accumulation. Surprisingly, rapid accumulation to high concentrations also occurred when cells were exposed to the GSH–ITC conjugates. However, these conjugates were apparently not absorbed intact, but were hydrolyzed extracellularly to free ITCs that were taken up by the cells. This conclusion is supported by the finding that suppression of dissociation of the conjugates by excess GSH or other thiols blocks accumulation of the conjugates.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. K. Brown, F. H. Blaikie, R. A. J. Smith, J. D. A. Tyndall, H. Lue, J. Bernhagen, C. C. Winterbourn, and M. B. Hampton Direct Modification of the Proinflammatory Cytokine Macrophage Migration Inhibitory Factor by Dietary Isothiocyanates J. Biol. Chem., November 20, 2009; 284(47): 32425 - 32433. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Malaguti, C. Angeloni, N. Garatachea, M. Baldini, E. Leoncini, P. S. Collado, G. Teti, M. Falconi, J. Gonzalez-Gallego, and S. Hrelia Sulforaphane treatment protects skeletal muscle against damage induced by exhaustive exercise in rats J Appl Physiol, October 1, 2009; 107(4): 1028 - 1036. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. Sahu, R. Zhang, S. Batra, Y. Shi, and S. K. Srivastava Benzyl isothiocyanate-mediated generation of reactive oxygen species causes cell cycle arrest and induces apoptosis via activation of MAPK in human pancreatic cancer cells Carcinogenesis, October 1, 2009; 30(10): 1744 - 1753. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Dickinson, T. F. Melton, E. R. Olson, J. Zhang, K. Saboda, and G. T. Bowden Inhibition of Activator Protein-1 by Sulforaphane Involves Interaction with Cysteine in the cFos DNA-Binding Domain: Implications for Chemoprevention of UVB-Induced Skin Cancer Cancer Res., September 1, 2009; 69(17): 7103 - 7110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Mi, X. Wang, S. Govind, B. L. Hood, T. D. Veenstra, T. P. Conrads, D. T. Saha, R. Goldman, and F.-L. Chung The Role of Protein Binding in Induction of Apoptosis by Phenethyl Isothiocyanate and Sulforaphane in Human Non-Small Lung Cancer Cells Cancer Res., July 1, 2007; 67(13): 6409 - 6416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. S. Cornblatt, L. Ye, A. T. Dinkova-Kostova, M. Erb, J. W. Fahey, N. K. Singh, M.-S. A. Chen, T. Stierer, E. Garrett-Mayer, P. Argani, et al. Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast Carcinogenesis, July 1, 2007; 28(7): 1485 - 1490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Fowke, J. D. Morrow, S. Motley, R. M. Bostick, and R. M. Ness Brassica vegetable consumption reduces urinary F2-isoprostane levels independent of micronutrient intake Carcinogenesis, October 1, 2006; 27(10): 2096 - 2102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Myzak, K. Hardin, R. Wang, R. H. Dashwood, and E. Ho Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells Carcinogenesis, April 1, 2006; 27(4): 811 - 819. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-T. Yeh and G.-C. Yen Effect of sulforaphane on metallothionein expression and induction of apoptosis in human hepatoma HepG2 cells Carcinogenesis, December 1, 2005; 26(12): 2138 - 2148. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Tang and Y. Zhang Mitochondria are the primary target in isothiocyanate-induced apoptosis in human bladder cancer cells Mol. Cancer Ther., August 1, 2005; 4(8): 1250 - 1259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Tseng, E. A. Scott-Ramsay, and M. E. Morris Dietary Organic Isothiocyanates Are Cytotoxic in Human Breast Cancer MCF-7 and Mammary Epithelial MCF-12A Cell Lines Experimental Biology and Medicine, September 1, 2004; 229(8): 835 - 842. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Tang and Y. Zhang Dietary Isothiocyanates Inhibit the Growth of Human Bladder Carcinoma Cells J. Nutr., August 1, 2004; 134(8): 2004 - 2010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Pullar, S. J. Thomson, M. J. King, C. I. Turnbull, R. G. Midwinter, and M. B. Hampton The chemopreventive agent phenethyl isothiocyanate sensitizes cells to Fas-mediated apoptosis Carcinogenesis, May 1, 2004; 25(5): 765 - 772. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.-R. Kim, R. Hu, Y.-S. Keum, V. Hebbar, G. Shen, S. S. Nair, and A-N. T. Kong Effects of Glutathione on Antioxidant Response Element-Mediated Gene Expression and Apoptosis Elicited by Sulforaphane Cancer Res., November 1, 2003; 63(21): 7520 - 7525. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhang, V. Svehlikova, Y. Bao, A.F. Howie, G. J. Beckett, and G. Williamson Synergy between sulforaphane and selenium in the induction of thioredoxin reductase 1 requires both transcriptional and translational modulation Carcinogenesis, March 1, 2003; 24(3): 497 - 503. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Brooks, M. F. Goldberg, L. A. Nelson, D. Wu, and W. G. Nelson Identification of Potential Prostate Cancer Preventive Agents through Induction of Quinone Reductase in Vitro Cancer Epidemiol. Biomarkers Prev., September 1, 2002; 11(9): 868 - 875. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. P. Basten, Y. Bao, and G. Williamson Sulforaphane and its glutathione conjugate but not sulforaphane nitrile induce UDP-glucuronosyl transferase (UGT1A1) and glutathione transferase (GSTA1) in cultured cells Carcinogenesis, August 1, 2002; 23(8): 1399 - 1404. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Krul, C. Humblot, C. Philippe, M. Vermeulen, M. van Nuenen, R. Havenaar, and S. Rabot Metabolism of sinigrin (2-propenyl glucosinolate) by the human colonic microflora in a dynamic in vitro large-intestinal model Carcinogenesis, June 1, 2002; 23(6): 1009 - 1016. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Fahey, X. Haristoy, P. M. Dolan, T. W. Kensler, I. Scholtus, K. K. Stephenson, P. Talalay, and A. Lozniewski Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors PNAS, May 28, 2002; 99(11): 7610 - 7615. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Ye and Y. Zhang Total intracellular accumulation levels of dietary isothiocyanates determine their activity in elevation of cellular glutathione and induction of Phase 2 detoxification enzymes Carcinogenesis, December 1, 2001; 22(12): 1987 - 1992. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Brooks, V. G. Paton, and G. Vidanes Potent Induction of Phase 2 Enzymes in Human Prostate Cells by Sulforaphane Cancer Epidemiol. Biomarkers Prev., September 1, 2001; 10(9): 949 - 954. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Shapiro, J. W. Fahey, K. L. Wade, K. K. Stephenson, and P. Talalay Chemoprotective Glucosinolates and Isothiocyanates of Broccoli Sprouts: Metabolism and Excretion in Humans Cancer Epidemiol. Biomarkers Prev., May 1, 2001; 10(5): 501 - 508. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Zhang Molecular mechanism of rapid cellular accumulation of anticarcinogenic isothiocyanates Carcinogenesis, March 1, 2001; 22(3): 425 - 431. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Heiss, C. Herhaus, K. Klimo, H. Bartsch, and C. Gerhauser Nuclear Factor kappa B Is a Molecular Target for Sulforaphane-mediated Anti-inflammatory Mechanisms J. Biol. Chem., August 17, 2001; 276(34): 32008 - 32015. [Abstract] [Full Text] [PDF]
|
|